Stock Report

All about this stock under one free report Last Updated: 17-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Standard Medical & Pharmaceuticals Ltd.

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 511042

₹ --

₹ -- (--%)

As on --

Market cap

info icon

₹3 Cr

Revenue (TTM)

info icon

₹-- Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.2

Div. Yield

info icon

0 %

Standard Medical & Pharm Share Price

Compare

Max:loading Min:loading

Max:loading Min:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: High:

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹0 Cr

  • ROEROE information

    0 %

  • ROCEROCE information

    0 %

  • Industry P/EIndustry P/E information

    51.37

  • EV/EBITDAEV/EBITDA information

    -514.4

  • Debt to EquityDebt to Equity information

    -1

  • Book ValueBook Value information

    ₹--

  • EPSEPS information

    ₹-0

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    10,845,700

10 Years Aggregate

CFO

0.61 Cr

EBITDA

-1.57 Cr

Net Profit

-0.08 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
BSE Sensex
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
BSE 500
-5.1 1.4 -3.5 -0.4 12.7 12.1 13.0
As on 15-May-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ( Cr)

Annual

*All values are in ( Cr)

Annual

*All values are in ( Cr)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Standard Medical & Pharm

Wholesale of scientific, medical and surgical machinery and equipment

  • Incorporated

    1983

  • Chairman

    --

  • Managing Director

    Srinivasa Raju Godavarthi

  • Headquarters

    Hyderabad, Telangana

  • Website

    www.smplindia.co.in

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Standard Medical & Pharm

Since, TTM earnings of Standard Medical & Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Standard Medical & Pharmaceuticals Ltd is -0.23 times as on 19-Dec-2001, a 125 discount to its peers’ median range of 0.91 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2017
0.00
0.00
2016
0.00
0.00
2015
0.00
0.00
2014
0.00
0.00
2013
0.00
0.00

The 52-week high and low of Standard Medical & Pharmaceuticals Ltd are Rs -- and Rs -- as of 17-May-2026.

Standard Medical & Pharmaceuticals Ltd has a market capitalisation of ₹ 3 Cr as on 19-Dec-2001. As per SEBI classification, it is a company.

Before investing in Standard Medical & Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.